Marea Therapeutics: Clinical Trials

5 trials sponsored by Marea Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 completed. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 3, Completed 1
Phase 12Completed 1, Recruiting 1

Follow Marea Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate MAR002 for Acromegaly
MAR002, Placebo - Acromegaly
Phase 2RecruitingMarea Therapeutics722026-07-232026-09-11
A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
MAR001, Placebo - Hypertriglyceridemia
Phase 2RecruitingMarea Therapeutics302025-09-262025-11-06
Study of MAR002 in Healthy Men
MAR002, Placebo - Acromegaly
Phase 1RecruitingMarea Therapeutics452025-08-112026-01-12
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
MAR001, Placebo - Hypertriglyceridemia
Phase 2RecruitingMarea Therapeutics3162025-06-302026-11-20
Study of MAR001 in Adults With Metabolic Dysfunction
MAR001, Placebo - Hypertriglyceridemia
Phase 1 / Phase 2CompletedMarea Therapeutics552023-07-222025-11-13

Conditions studied

Hypertriglyceridemia (3)  ·  Acromegaly (2)

Countries

United States (4)  ·  Australia (2)  ·  Canada (1)  ·  New Zealand (1)

Top investigators

Alex DePaoli (1)

Results publications

PMID 40383129, PMID 43002172